Ki-Hyun Jeon

Ki-Hyun Jeon

Auto-generated profile, based on publicly available information

Ki-Hyun Jeon


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYounghoon Cho
Younghoon Cho
JKJoon-myoung Kwon
Joon-myoung Kwon
KKKyung-hee Kim
Kyung-hee Kim
JMJose R. Medina-Inojosa
Jose R. Medina-Inojosa
KJKi-Hyun Jeon
Ki-Hyun Jeon
BOByung-Hee Oh
Byung-Hee Oh
Rapid diagnosis of myocardial infarction (MI) using electrocardiography (ECG) is the cornerstone of effective treatment and prevention of mortality; however, conventional interpretation methods has low reliability for detecting MI and is difficulty to apply to limb 6-lead ECG based life type or wearable devices. We developed and validated a deep learning-based artificial intelligence algorithm (DLA) for detecting MI using 6-lead ECG. A total of 412,461 ECGs were used to develop a variational autoencoder (VAE) that reconstructed precordial 6-lead ECG using limb 6-lead ECG. Data from 9536, 1301, and 1768 ECGs of adult patients who underwent coronary angiography within 24 h from each ECG were used for development, internal and external validation, respectively. During internal and external validation, the area under the receiver operating characteristic curves of the DLA with VAE using a 6-lead ECG were 0.880 and 0.854, respectively, and the performances were preserved by the territory of the coronary lesion. Our DLA successfully detected MI using a 12-lead ECG or a 6-lead ECG. The results indicate that MI could be detected not only with a conventional 12 lead ECG but also with a life type 6-lead ECG device that employs our DLA.

1 January 2019 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JKJoon-myoung Kwon
Joon-myoung Kwon
KKKyung-hee Kim
Kyung-hee Kim
KJKi-Hyun Jeon
Ki-Hyun Jeon
HKHyue Mee Kim
Hyue Mee Kim
MKMin Jeong Kim
Min Jeong Kim
BOByung-Hee Oh
Byung-Hee Oh
Kwon JM, et al. Korean Circ J. 2018 Aug;49:e56. https://doi.org/10.4070/kcj.2018.0446

1 July 2020 in The Lancet Digital Health
Verified
Journal Article
Open access
JKJoon-Myoung Kwon
Joon-Myoung Kwon
YCYounghoon Cho
Younghoon Cho
KJKi-Hyun Jeon
Ki-Hyun Jeon
SCSoohyun Cho
Soohyun Cho
KKKyung-Hee Kim
Kyung-Hee Kim
BOByung-Hee Oh
Byung-Hee Oh
Anaemia is an important health-care burden globally, and screening for anaemia is crucial to prevent multi-organ injury, irreversible complications, and life-threatening adverse events. We aimed to establish whether a deep learning algorithm (DLA) that enables non-invasive anaemia screening from electrocardiograms (ECGs) might improve the detection of anaemia. We did a retrospective, multicentre, diagnostic study in which a DLA was developed using ECGs and then internally and externally validated. We used data from two hospitals, Sejong General Hospital (hospital A) and Mediplex Sejong Hospital (hospital B), in South Korea. Data from hospital A was for DLA development and internal validation, and data from hospital B was for external validation. We included individuals who had at least one ECG with a haemoglobin measurement within 1 h of the index ECG and excluded individuals with missing demographic, electrocardiographic, or haemoglobin information. Three types of DLA were developed with 12-lead, 6-lead (limb lead), and single-lead (lead I) ECGs to detect haemoglobin concentrations of 10 g/dL or less. The DLA was built by a convolutional neural network and used 500-Hz raw ECG, age, and sex as input data. The study period ran from Oct 1, 2016, to Sept 30, 2019, in hospital A and March 1, 2017, to Sept 30, 2019, in hospital B. 40 513 patients at hospital A and 4737 patients at hospital B were eligible for inclusion. We excluded 281 patients at hospital A and 72 patients at hospital B because of missing values for clinical information and ECG data. The development dataset comprised 57 435 ECGs from 31 898 patients, and the algorithm was internally validated with 7974 ECGs from 7974 patients. The external validation dataset included 4665 ECGs from 4665 patients. 586 (internal) and 194 (external) patients within the combined dataset were found to be anaemic. During internal and external validation, the area under the receiver operating characteristics curve (AUROC) of the DLA using a 12-lead ECG for detecting anaemia was 0·923 for internal validation and 0·901 for external validation. Using a 90% sensitivity operating point for the development data, the sensitivity, specificity, negative predictive value, and positive predictive value of internal validation were 89·8%, 81·5%, 99·4%, and 20·0%, respectively, and those of external validation were 86·1%, 76·2%, 99·2%, and 13·5%, respectively. The DLA focused on the QRS complex for deciding the presence of anaemia in a sensitivity map. The AUROCs of DLAs using 6 leads and a single lead were in the range of 0·841-0·890. In this study, using raw ECG data, a DLA accurately detected anaemia. The application of artificial intelligence to ECGs could enable screening for anaemia. None.

1 June 2019 in Resuscitation
Verified
Journal Article
Closed access
JKJoon-myoung Kwon
Joon-myoung Kwon
KJKi-Hyun Jeon
Ki-Hyun Jeon
HKHyue Mee Kim
Hyue Mee Kim
MKMin Jeong Kim
Min Jeong Kim
SLSungmin Lim
Sungmin Lim
BOByung-Hee Oh
Byung-Hee Oh

4 December 2019 in EP Europace
Verified
Journal Article
Closed access
JKJoon-myoung Kwon
Joon-myoung Kwon
KJKi-Hyun Jeon
Ki-Hyun Jeon
HKHyue Mee Kim
Hyue Mee Kim
MKMin Jeong Kim
Min Jeong Kim
SLSung Min Lim
Sung Min Lim
BOByung-Hee Oh
Byung-Hee Oh
Aims : Although left ventricular hypertrophy (LVH) has a high incidence and clinical importance, the conventional diagnosis criteria for detecting LVH using electrocardiography (ECG) has not been satisfied. We aimed to develop an artificial intelligence (AI) algorithm for detecting LVH. Methods and results: This retrospective cohort study involved the review of 21 286 patients who were admitted to two hospitals between October 2016 and July 2018 and underwent 12-lead ECG and echocardiography within 4 weeks. The patients in one hospital were divided into a derivation and internal validation dataset, while the patients in the other hospital were included in only an external validation dataset. An AI algorithm based on an ensemble neural network (ENN) combining convolutional and deep neural network was developed using the derivation dataset. And we visualized the ECG area that the AI algorithm used to make the decision. The area under the receiver operating characteristic curve of the AI algorithm based on ENN was 0.880 (95% confidence interval 0.877–0.883) and 0.868 (0.865–0.871) during the internal and external validations. These results significantly outperformed the cardiologist’s clinical assessment with Romhilt-Estes point system and Cornell voltage criteria, Sokolov-Lyon criteria, and interpretation of ECG machine. At the same specificity, the AI algorithm based on ENN achieved 159.9%, 177.7%, and 143.8% higher sensitivities than those of the cardiologist’s assessment, Sokolov-Lyon criteria, and interpretation of ECG machine. Conclusion : An AI algorithm based on ENN was highly able to detect LVH and outperformed cardiologists, conventional methods, and other machine learning techniques.

16 July 2020 in ASAIO Journal
Verified
Journal Article
Closed access
JCJinwoo Cho
Jinwoo Cho
BLByeongTak Lee
ByeongTak Lee
JKJoon-myoung Kwon
Joon-myoung Kwon
YLYeha Lee
Yeha Lee
HPHyunho Park
Hyunho Park
KKKyung-hee Kim
Kyung-hee Kim
Although heart failure with reduced ejection fraction (HFrEF) is a common clinical syndrome and can be modified by the administration of appropriate medical therapy, there is no adequate tool available to perform reliable, economical, early-stage screening. To meet this need, we developed an interpretable artificial intelligence (AI) algorithm for HFrEF screening using electrocardiography (ECG) and validated its performance. This retrospective cohort study included two hospitals. An AI algorithm based on a convolutional neural network was developed using 39,371 ECG results from 17,127 patients. The internal validation included 3,470 ECGs from 2,908 patients. Furthermore, we conducted external validation using 4,362 ECGs from 4,176 patients from another hospital to verify the applicability of the algorithm across different centers. The end-point was to detect HFrEF, defined as an ejection fraction <40%. We also visualized the regions in 12 lead ECG that affected HFrEF detection in the AI algorithm and compared this to the previously documented literature. During the internal and external validation, the areas under the curves of the AI algorithm using a 12 lead ECG for detecting HFrEF were 0.913 (95% confidence interval, 0.902–0.925) and 0.961 (0.951–0.971), respectively, and the areas under the curves of the AI algorithm using a single-lead ECG were 0.874 (0.859–0.890) and 0.929 (0.911–0.946), respectively. The deep learning-based AI algorithm performed HFrEF detection well using not only a 12 lead but also a single-lead ECG. These results suggest that HFrEF can be screened not only using a 12 lead ECG, as is typical of a conventional ECG machine, but also with a single-lead ECG performed by a wearable device employing the AI algorithm, thereby preventing irreversible disease progression and mortality.